SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-21-027684
Filing Date
2021-04-20
Accepted
2021-04-20 19:55:14
Documents
1
Period of Report
2021-04-19

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 3111
  Complete submission text file 0001209191-21-027684.txt   4602
Mailing Address 4260 U.S. ROUTE 1 MONMOUTH JUNCTION NJ 08852
Business Address 4260 U.S. ROUTE 1 MONMOUTH JUNCTION NJ 08852 6096193990
Outlook Therapeutics, Inc. (Issuer) CIK: 0001649989 (see all company filings)

IRS No.: 383982704 | State of Incorp.: DE | Fiscal Year End: 0930
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 7TH CIRCLE, ZAHRAN ST. ZAHRAN PLAZA BLDG,4TH FLR, PO BOX 142909 AMMAN M2 11844
Business Address
Sukhtian Faisal Ghiath (Reporting) CIK: 0001716033 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37759 | Film No.: 21839203